Permethrin Cream, 5% + Elimite
Phase 3Completed 0 views this week 0 watching💤 Quiet
Interest: 30/100
30
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Scabies
Conditions
Scabies
Trial Timeline
Nov 1, 2016 → May 1, 2017
NCT ID
NCT02978508About Permethrin Cream, 5% + Elimite
Permethrin Cream, 5% + Elimite is a phase 3 stage product being developed by Mayne Pharma Group for Scabies. The current trial status is completed. This product is registered under clinical trial identifier NCT02978508. Target conditions include Scabies.
What happened to similar drugs?
1 of 2 similar drugs in Scabies were approved
Approved (1) Terminated (0) Active (1)
Hype Score Breakdown
Clinical
17
Activity
8
Company
5
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02978508 | Phase 3 | Completed |
Competing Products
3 competing products in Scabies
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| Permethrin | Dr. Reddy's Laboratories | Phase 3 | 37 |
| Spinosad Topical | Inotiv | Approved | 40 |
| Permethrin Foam 4% + Permethrin Foam 5% + Vehicle Foam | Viatris | Phase 2 | 32 |